<DOC>
	<DOCNO>NCT01830426</DOCNO>
	<brief_summary>The purpose study establish circulate tumor cell ( CTC ) assay surrogate tissue diagnosis suspect primary lung cancer . This do evaluate clinical molecular marker stratify outcome/survival patient thoracic malignancy treat Yale University/Yale-New Haven Hospital , University California San Diego/Moores Cancer Center , Billings Clinic Cancer Center .</brief_summary>
	<brief_title>Circulating Tumor Cells Non-Small Cell Lung Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Suspected lung cancer Planned undergo tissue biopsy . Tissue biopsy need limited intrathoracic structure . Biopsies supraclavicular lymph node allow Age &gt; 18 Patients history separate ( primary lung cancer ) malignancy within past two year . Recent history ( past two week ) trauma ( INCLUDING diagnostic surgery , biopsy , etc ) Prior lung cancer treatment chemotherapy , radiation , surgery , etc . past two year . Inability provide inform consent . Hgb le 8 .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>